| 药品名称 | 活性成分 | 中文名 | 剂型 | ATC编码 | 参照成员国 | 上市许可持有人 | 获批时间 | 市场状态 |
|---|---|---|---|---|---|---|---|---|
| Zemplar 5 microgram/ml Solution for Injection | Paricalcitol5mcg/ml | 帕立骨化醇 | Solution for injection | 西班牙 | Abbott Laboratories, S.A. | 2003-03-27 | Positive | |
| Paricalcitol "Pharmathen" | paricalcitol2µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 丹麦 | Pharmathen S.A. | 2013-09-11 | Positive |
| Porontazin 1 micrograms capsules, soft | Paricalcitol1µg | 帕立骨化醇 | Capsule, soft | H05BX02 | 荷兰 | Regiomedica GmbH | 2014-03-14 | Positive |
| Paricalcitol Normon | paricalcitol5µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 葡萄牙 | Laboratórios Normon, S.A. PT | 2013-12-03 | Positive |
| Paricalcitol Accord 2 microgram/ml solution for injection | Paricalcitol2µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 荷兰 | Accord Healthcare Limited. | 2015-01-19 | Positive |
| Paricalcitol "Hameln" | paricalcitol5µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 丹麦 | Siegfried Hameln Services GmbH | 2014-03-19 | Withdrawn |
| Paricalcitol Hospira | paricalcitol5µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 葡萄牙 | Hospira Portugal, Lda. | 2011-05-06 | Positive |
| Zemplar 1 microgram capsules, soft | paricalcitol1mcg | 帕立骨化醇 | Capsule, soft | 西班牙 | Abbott Laboratories, S.A. | 2007-10-30 | Positive | |
| Paricalcitol HEXAL 2 Mikrogramm/ml Injektionslösung | Paricalcitol2µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 德国 | H e x a lAktiengesellschaft | 2014-01-07 | Positive |
| Paricalcimed | paricalcitol5µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 葡萄牙 | Pharmabide, Ltd. | 2015-04-22 | Positive |
| Paricalcitol Pharmabide | paricalcitol5µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 葡萄牙 | Pharmabide Ltd | 2011-07-27 | Positive |
| Paricalcitol Accord 5 microgram/ml solution for injection | Paricalcitol5µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 荷兰 | Accord Healthcare Limited. | 2015-01-19 | Positive |
| Paricalcitol Aurovitas | paricalcitol5µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 葡萄牙 | Aurovitas Unipessoal, Lda. | 2018-06-25 | Positive |
| Paricalcitol Pharmabide | paricalcitol2µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 葡萄牙 | Pharmabide Ltd | 2011-07-27 | Positive |
| Paricalcitol AGmed | paricalcitol2µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 捷克 | XANTIS PHARMA LIMITED | 2019-04-23 | Positive |
| Paricalcitol SUN 2 Mikrogramm/ml Injektionslösung | paricalcitol2µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 德国 | Sun Pharmaceuticals Germany GmbH | 2013-08-21 | Positive |
| Paricalcitol | paricalcitol5U/g | 帕立骨化醇 | Solution for injection | H05BX02 | 德国 | betapharm Arzneimittel GmbH | 2014-01-29 | Positive |
| Paricalcitol Stada 1 microgramo cápsulas blandas EFG | Paricalcitol1µg | 帕立骨化醇 | Capsule, soft | H05BX02 | 西班牙 | Laboratorio Stada S.L. | 2014-03-14 | Positive |
| Paricalcimed | paricalcitol2µg/ml | 帕立骨化醇 | Solution for injection | H05BX02 | 葡萄牙 | Pharmabide, Ltd. | 2015-04-22 | Positive |
| Rextol | paricalcitol4µg | 帕立骨化醇 | Capsule, soft | H05BX02 | 葡萄牙 | Rafarm, SA | 2015-11-09 | Positive |
